Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-196312

Chief Financial Officer acquired 400 shares (grant or award)

  • Chief Financial Officer gave up 144 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mokari Atabak Chief Financial Officer 2025-09-02 Grant or award +200 $71.38 $14,276 14,265 D: show line 1 in the form
Mokari Atabak Chief Financial Officer 2025-09-02 Grant or award +200 14,465 D: show line 2 in the form
Mokari Atabak Chief Financial Officer 2025-09-03 Shares withheld for taxes −144 $71.38 $10,279 14,321 D: show line 3 in the form
Loading xslF345X05/ownership.xml…